EGFR and neoplasm: In the case of EGFR mutant tumours, DUSP6/MKP-3 loss appears secondary to down regulation of the transcription factor and ERK signalling target Ets1, while the mechanism of DUSP6/MKP-3 down regulation in ELM4–ALK tumour cells was not studied.